- Home
- EEFT vs BPMC Comparison
EEFT vs BPMC Comparison
Compare EEFT & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEFT
- BPMC
- Stock Information
- Founded
- EEFT 1994
- BPMC 2008
- Country
- EEFT United States
- BPMC United States
- Employees
- EEFT N/A
- BPMC N/A
- Industry
- EEFT EDP Services
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- EEFT Technology
- BPMC Health Care
- Exchange
- EEFT Nasdaq
- BPMC Nasdaq
- Market Cap
- EEFT 4.5B
- BPMC 5.2B
- IPO Year
- EEFT 1997
- BPMC 2015
- Fundamental
- Price
- EEFT $102.19
- BPMC $96.93
- Analyst Decision
- EEFT Buy
- BPMC Buy
- Analyst Count
- EEFT 8
- BPMC 19
- Target Price
- EEFT $126.14
- BPMC $120.79
- AVG Volume (30 Days)
- EEFT 296.3K
- BPMC 700.7K
- Earning Date
- EEFT 10-23-2024
- BPMC 10-30-2024
- Dividend Yield
- EEFT N/A
- BPMC N/A
- EPS Growth
- EEFT 27.95
- BPMC N/A
- EPS
- EEFT 6.88
- BPMC N/A
- Revenue
- EEFT $3,900,200,000.00
- BPMC $434,415,000.00
- Revenue This Year
- EEFT $10.36
- BPMC $108.13
- Revenue Next Year
- EEFT $7.91
- BPMC $38.91
- P/E Ratio
- EEFT $14.85
- BPMC N/A
- Revenue Growth
- EEFT 8.46
- BPMC 100.93
- 52 Week Low
- EEFT $81.99
- BPMC $62.56
- 52 Week High
- EEFT $117.66
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- EEFT 54.39
- BPMC 60.32
- Support Level
- EEFT $101.76
- BPMC $96.52
- Resistance Level
- EEFT $105.00
- BPMC $103.55
- Average True Range (ATR)
- EEFT 2.84
- BPMC 3.65
- MACD
- EEFT 0.34
- BPMC 1.09
- Stochastic Oscillator
- EEFT 68.03
- BPMC 70.84
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. The company operates an independent network of ATMs in Europe, along with a network for prepaid products such as mobile top-ups, and processes point-of-sale transactions. It operates in three segment EFT Processing Segment, epay Segment, and Money Transfer Segment. Its segment revenue comes from by operating income, electronical financial transaction processing, mainly generates revenue from monthly ATM management fees and currency conversion transactions. It generates the majority if its geographic revenue from the United States of America.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.